ENGLEWOOD, Colo., May 19, 2011 /PRNewswire/ -- In response to growing concerns about how to safely administer over-the-counter(OTC) liquid medications to children and the recent FDA Guidance for Industry on OTC delivery devices, Baxa Corporation, the leading provider of oral liquid drug delivery syringes, is available to discuss the following best practices for safe
A February 2010 study of more than 300 parents published in the Archives of Pediatric & Adolescent Medicine found that, when using a dosing cup with printed markings, 70% of parents made mistakes and almost all mistakes involved administering too much medicine.
"When giving my children oral medication, I prefer to measure and administer the medication using a syringe rather than a cup," said Colin Sox, MD, MS, a general pediatrician in Boston. "Oral syringes not only allow for more precise dosage, but also make administering medicine much easier, especially for young children."
According to a recent study published in the Journal of the American Medical Association that evaluated 200 OTC liquid drug products, of the 75% of products that came with a dosage delivery device, 98.6% had at least one mismatch between the device and the written dosing directions.
"The recent Food and Drug Administration guidance for orally ingested OTC liquid drug products is an important wake-up call to the industry and a much-needed rallying cry for parents who rely on drug manufacturers to produce medication that is safe and easy to administer," said Greg Baldwin, CEO of Baxa Corporation. "As the inventor of the first oral syringe in 1975 and an innovator of fluid drug delivery systems, Baxa is committed to providing solutions that advance the safe delivery of all liquid medications and reduce the risk of dosing error."
For more information about Baxa and to download the recent FDA Guidance, please visit: http://www.baxa.com/oem/downloads.html
To schedule an interview with Baxa and for all media inquiries:Perrin McCormick or Brandie GerrishHB firstname.lastname@example.org
SOURCE Baxa Corporation
Subscribe to our Free Newsletters!